Informations générales (source: ClinicalTrials.gov)
Multicentre Validation of a Fetal Urine Peptidome-based Classifier to Predict Post-natal Renal Function in Posterior Urethral Valves
Observational
University Hospital, Toulouse (Voir sur ClinicalTrials)
juin 2017
décembre 2023
12 septembre 2025
Validate the use of fetal urine peptidome-analysis and explore amniotic fluid markers for
the stratification of fetuses with Posterior Urethral Valve for post-natal renal
function.
Etablissements
| Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| AP-HP - Hôpital Necker-Enfants Malades | Yves VILLE, Pr | Contact (sur clinicalTrials) | |||
| HOPITAL NOVO | vendredi 5 septembre 2025 | Contact (sur clinicalTrials) | |||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| Centre hospitalier universitaire Chu Amiens Salouël Hôpital sud - 80480 - Salouel - France | Contact (sur clinicalTrials) | ||||
| Centre Hospitalier Universitaire de Montpellier - 34295 - Montpellier - France | Contact (sur clinicalTrials) | ||||
| Centre Olympe de Gouges du CHRU de Tours - 37000 - Tours - France | Franck PERROTIN, Pr | Contact (sur clinicalTrials) | |||
| CHRU de Brest - Hôpital Morvan - 29609 - Brest - France | Contact (sur clinicalTrials) | ||||
| CHU de Grenoble - Hôpital Couple-Enfant - Département de la Génétique - 38043 - Grenoble - France | Contact (sur clinicalTrials) | ||||
| CHU de la Timone - 13385 - Marseille - France | Contact (sur clinicalTrials) | ||||
| CHU Estaing - 63100 - Clermont-Ferrand - France | Helene LAURICHESSE, Dr | Contact (sur clinicalTrials) | |||
| CHU Hôpitaux de St-Etienne-Hôpital Nord - 42055 - Saint Etienne - France | Contact (sur clinicalTrials) | ||||
| CHU Lenval - 06200 - Nice - France | Elizabeth SIMON, Dr | Contact (sur clinicalTrials) | |||
| CHU Pellegrin-Bordeaux - 33078 - Bordeaux - France | Contact (sur clinicalTrials) | ||||
| CHU Poitiers - 86021 - Poitiers - France | Contact (sur clinicalTrials) | ||||
| CHU Rennes Hôpital Sud - 35000 - Rennes - France | Contact (sur clinicalTrials) | ||||
| Hôpital Bagatelle (Talence) - CHU Pellegrin (Bordeaux) - 33400 - Talence - France | Anne PARIS, Dr | Contact (sur clinicalTrials) | |||
| Hôpital Femme Mère Enfant-Lyon - 69677 - Bron - France | Contact (sur clinicalTrials) | ||||
| Hôpital mère-enfant pédiatrie - 44093 - Nantes - France | Norbert WINER, Dr | Contact (sur clinicalTrials) | |||
| Hôpital Paule de Viguier-Hôpital des enfants- Site Purpan - 31059 - Toulouse - France | Stéphane Decramer, Pr | Contact (sur clinicalTrials) | |||
| Hôpital Robert-Debré - 75019 - Paris - France | Jonathan ROSENBLATT, Dr | Contact (sur clinicalTrials) | |||
| Sihcus-Cmco - 67300 - Schiltigheim - France | Romain FAVRE, Pr | Contact (sur clinicalTrials) | |||
Critères
Femme
Inclusion Criteria:
- male singleton fetus with megabladder associated with urinary tract anomalies with
or without dysplastic or hyperechogenic parenchyma detected in a first ultrasound;
- megabladder confirmed in a second ultrasound;
- collection of fetal urine taken during the routine management of the disease for the
dosage of ß2-microglobulin;
- written informed consent.
- male singleton fetus with megabladder associated with urinary tract anomalies with
or without dysplastic or hyperechogenic parenchyma detected in a first ultrasound;
- megabladder confirmed in a second ultrasound;
- collection of fetal urine taken during the routine management of the disease for the
dosage of ß2-microglobulin;
- written informed consent.
- refusal to participate in the study;
- person protected by law.